{"product_id":"atricure-business-model-canvas","title":"AtriCure Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAtriCure's Business Model: A Deep Dive\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock the full strategic blueprint behind AtriCure’s business model. This in-depth Business Model Canvas reveals how the company drives value in cardiac surgery, captures market share with innovative solutions, and stays ahead in a competitive landscape. Ideal for entrepreneurs, consultants, and investors looking for actionable insights into a thriving medical device company.\u003c\/p\u003e\n\u003cp\u003eDive deeper into AtriCure’s real-world strategy with the complete Business Model Canvas. From unique value propositions addressing unmet clinical needs to its cost structure and revenue streams, this downloadable file offers a clear, professionally written snapshot of what makes this company thrive—and where its future opportunities lie.\u003c\/p\u003e\n\u003cp\u003eWant to see exactly how AtriCure operates and scales its business in the complex healthcare sector? Our full Business Model Canvas provides a detailed, section-by-section breakdown, perfect for benchmarking your own strategy, conducting thorough market analysis, or preparing compelling investor presentations.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHospitals and Surgical Centers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eHospitals and surgical centers are AtriCure's primary partners, crucial for adopting and integrating their AtriClip and EPi-Sense systems into cardiac surgical workflows. Securing volume-based purchasing agreements with these institutions is vital, with the global cardiac surgery market projected to reach $15.8 billion by 2024. These partnerships also provide essential feedback loops for product enhancements and clinical data collection, supporting ongoing innovation and market penetration for AtriCure's ablation technologies.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGroup Purchasing Organizations (GPOs)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGroup Purchasing Organizations, or GPOs, are crucial for AtriCure's market access and sales efficiency, representing vast hospital networks and negotiating product pricing. Securing contracts with major GPOs like Vizient and Premier streamlines procurement for their member hospitals. These partnerships make AtriCure's products more accessible and competitively priced, especially given that GPOs influence over 90% of healthcare supply chain spending in the U.S. This strategy is key to scaling sales across the healthcare system, ensuring broader adoption of AtriCure's innovative solutions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInternational Distributors\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAtriCure significantly expands its global footprint by leveraging a robust network of specialized medical device distributors across Europe, Asia, and other key international markets. These partners are crucial, possessing deep local market knowledge and established relationships with regional hospitals. They expertly navigate complex local regulatory and reimbursement landscapes, which is vital for market penetration. This collaborative approach is essential for driving considerable revenue growth outside the United States, with international sales contributing meaningfully to the company’s overall performance, for example, reflecting continued expansion in 2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eKey Opinion Leaders (KOLs) and Academic Medical Centers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eCollaborations with influential cardiothoracic surgeons, electrophysiologists, and leading academic hospitals are fundamental to AtriCure's strategy. These Key Opinion Leaders (KOLs) act as advocates, driving peer-to-peer adoption and leading critical clinical trials. Partnerships with academic centers often result in published clinical data, validating the technology, with AtriCure's 2024 clinical pipeline focusing on expanded indications. Such alliances are crucial for market penetration and product evolution.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\u003cstrong\u003eKOLs influence peer adoption, crucial for new device integration.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eAcademic centers provide platforms for clinical evidence generation.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePublished data enhances credibility and market acceptance.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eInsights from these partnerships inform next-generation product development.\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Technology and Component Suppliers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAtriCure relies on strategic partnerships with specialized suppliers to secure critical components and raw materials for their advanced medical devices, ensuring product efficacy and safety. These relationships are meticulously managed to uphold stringent quality standards and maintain compliance with regulatory requirements, crucial for devices like those used in atrial fibrillation procedures. Collaborations with technology providers further enable the integration of innovative solutions, accelerating AtriCure's research and development pipeline. The company's 2024 operational efficiency greatly depends on these stable supply chains and technological alignments. \u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\u003cstrong\u003eCritical component supply agreements ensure device functionality.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eRegulatory compliance is a key focus in all supplier partnerships.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eStrategic tech collaborations drive innovation in cardiac ablation.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eSupply chain stability supports consistent product availability.\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Alliances Drive Cardiac Ablation Growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAtriCure's key partnerships include hospitals, GPOs, and global distributors, crucial for market access and sales efficiency. Collaborations with Key Opinion Leaders and academic centers drive clinical adoption and validate technologies, with the 2024 clinical pipeline focusing on expanded indications. Strategic supplier alliances ensure product quality and fuel innovation in cardiac ablation, supporting 2024 operational efficiency. These alliances collectively underpin AtriCure's growth.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003ePartnership Type\u003c\/th\u003e\n\u003cth\u003eStrategic Impact\u003c\/th\u003e\n\u003cth\u003e2024 Data\/Influence\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospitals\/Surgical Centers\u003c\/td\u003e\n\u003ctd\u003eMarket Adoption \u0026amp; Feedback\u003c\/td\u003e\n\u003ctd\u003eGlobal cardiac surgery market ~$15.8B by 2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGroup Purchasing Organizations\u003c\/td\u003e\n\u003ctd\u003eMarket Access \u0026amp; Pricing\u003c\/td\u003e\n\u003ctd\u003eGPOs influence \u0026gt;90% U.S. healthcare supply chain\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eKOLs\/Academic Centers\u003c\/td\u003e\n\u003ctd\u003eClinical Validation \u0026amp; Advocacy\u003c\/td\u003e\n\u003ctd\u003e2024 clinical pipeline focuses on expanded indications\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA comprehensive business model canvas detailing AtriCure's approach to treating atrial fibrillation and left atrial appendage closure, focusing on physician education and direct sales to hospitals.\u003c\/p\u003e\n\u003cp\u003eThis model highlights AtriCure's value proposition of improving patient outcomes through innovative medical devices and a robust support system for healthcare providers.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eAtriCure's Business Model Canvas offers a clear and structured way to understand how they address the pain points of cardiac surgeons and patients by mapping out their value proposition and key partners.\u003c\/p\u003e\n\u003cp\u003eThis one-page snapshot effectively highlights AtriCure's solutions for complex cardiac procedures, making it easy to grasp their approach to relieving critical medical challenges.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResearch and Development (R\u0026amp;D)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAtriCure's Research and Development is a core activity, driving innovation in ablation and surgical devices to enhance safety and efficacy for arrhythmia treatment. The company consistently invests in developing new products for both open and minimally invasive procedures, with a strong pipeline aimed at addressing unmet clinical needs. For instance, AtriCure's R\u0026amp;D expenses were $140.2 million in 2023, reflecting significant ongoing investment. This continuous product enhancement and development are crucial for maintaining a competitive edge and improving patient outcomes in 2024 and beyond.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eManufacturing and Quality Assurance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAtriCure operates FDA-registered and ISO-certified manufacturing facilities, central to its business model, to produce its advanced medical devices. This key activity demands stringent process controls, robust quality assurance protocols, and meticulous supply chain management, ensuring every product meets the highest safety and performance standards. Maintaining this critical level of quality is non-negotiable for medical device companies, directly impacting regulatory compliance and fostering unwavering customer trust. In 2024, the global medical device market continues to emphasize quality, with companies investing heavily to avoid the significant financial and reputational costs of non-compliance.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConducting Clinical Trials\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eA fundamental activity involves the design and execution of large-scale, multi-center clinical trials, such as the pivotal aMAZE and CONVERGE studies. These trials are essential for gathering robust clinical evidence, crucial for securing FDA approvals and favorable reimbursement, which directly impacts market adoption. The aMAZE trial results, for instance, supported the FDA approval of the AtriClip for persistent Afib patients, contributing to AtriCure's Q1 2024 revenue of $115.4 million. This comprehensive data serves as a cornerstone for their marketing and sales efforts, demonstrating treatment superiority and driving commercial success.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePhysician Training and Education\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAtriCure dedicates substantial resources to comprehensive training programs for surgeons, electrophysiologists, and operating room staff. These programs ensure that its sophisticated devices, like those used in left atrial appendage management, are utilized safely and effectively to achieve optimal patient outcomes. This hands-on training builds physician confidence, accelerating the adoption curve for new technologies and strengthening crucial customer relationships. For instance, in 2024, continued investment in such physician education remains a core strategy, supporting the company's projected revenue growth.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\u003cstrong\u003eAtriCure's investment in physician training directly correlates with market penetration for its ablation and LAA exclusion products.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eTraining initiatives enhance procedural proficiency, contributing to patient safety and efficacy in cardiac procedures.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eThe company actively supports workshops and peer-to-peer learning, crucial for widespread adoption of innovative therapies.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eEffective training helps drive demand, with AtriCure reporting strong sales growth in 2024, partly due to expanded clinical expertise among users.\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSales and Clinical Field Support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAtriCure, now integrated into Boston Scientific, relies on a specialized direct sales force and clinical support team for its commercial success in complex surgical products. This dedicated team engages directly with cardiac surgeons and hospital administrators, driving sales of their atrial fibrillation and left atrial appendage management solutions. Crucially, they provide real-time clinical support within the operating room during procedures, ensuring proper device utilization and immediate troubleshooting. This high-touch model, essential for intricate medical devices, contributed to Boston Scientific's cardiovascular segment’s strong performance, projected to grow mid-single digits in 2024.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\u003cstrong\u003eDirect sales force drives product adoption.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eClinical specialists offer vital OR support.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eEngages key stakeholders: surgeons and administrators.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eEnsures proper use and immediate issue resolution.\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInnovation to Impact: Driving Surgical Solutions and Market Growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAtriCure's key activities encompass continuous research and development, evidenced by significant 2023 investments, alongside stringent manufacturing to ensure product quality. They execute critical clinical trials, such as aMAZE, vital for securing FDA approvals and market adoption, contributing to Q1 2024 revenue of $115.4 million. Comprehensive training programs for surgeons and a direct sales force provide crucial in-OR support, driving product utilization and adoption, supporting projected mid-single digit growth in 2024 for their segment.\u003c\/p\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Version Awaits\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe AtriCure Business Model Canvas preview you are viewing is an exact representation of the document you will receive upon purchase. This isn't a sample or a mockup; it's a direct snapshot of the complete, ready-to-use file. When you complete your order, you'll gain full access to this same comprehensive document, ensuring you get precisely what you see, formatted and structured for immediate application.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":55480443994489,"sku":"atricure-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/atricure-business-model-canvas.png?v=1752753819","url":"https:\/\/growthsharematrix.com\/products\/atricure-business-model-canvas","provider":"Growth Share Matrix","version":"1.0","type":"link"}